Home   |   Site map   |   Contact   |   Legal    |    Version française

Novexel’s clear business goal is to develop novel antibacterial and anti-fungal agents that address the growing global problem of resistance...  more

To receive our press releases and newsletters, please enter your e-mail.

Novel therapies
for infectious disease  

ASTRAZENECA ACQUISITION OF NOVEXEL

Please be advised that AstraZeneca’s acquisition of Novexel completed on 3rd March 2010.    As a result, this website will not be updated regularly and all enquiries should be directed to ian.kirk@astrazeneca.com.

 

23/12/2009 Novexel to be acquired by AstraZeneca...

06/11/2009 Novexel Starts Phase II Clinical Trial with NXL103 in Adults...

11/09/2009 Novexel presents 16 posters and one slide presentation at th...

> More news

> See our 2009 Factsheet
> See all our publications
> See all our press releases
> Contact us
> Access map

To accomplish our mission we need people who enjoy working in a dynamic...